Diabète de type 2 | | thasso

Blog Archives

Le Parquet de Paris: le scandale du Mediator (benfluorex) continue

Posted on mai 26, 2017 by par

Joseph Gut - thasso Posté dans La Presse, Medicine Théragenomique, Réaction indésirable grave à un médicament, Thasso Poste Aucun commentaire ↓

26 mai 2017 – Scandale du Mediator (le benfluorex): le Parquet de Paris demande un procès pour les laboratoires Servier et l’Agence du médicament. Cet antidiabétique, interdit en 2009, est présumé responsable de la mort de centaines de personnes.

$Le parquet a annoncé avoir requis un renvoi du groupe pharmaceutique Servier pour \"tromperie aggravée, escroquerie, blessures et homicides involontaires et trafic d\'influence\".$ Le Parquet a annoncé avoir requis un renvoi du groupe pharmaceutique Servier pour tromperie aggravée,

…

Tags : Diabète de type 2, Fenfluramine, Irene Frachon, L'affaire du Mediator, l'Agence nationale de sécurité du médicament (ANSM), La fille de Brest, Laboratoires Servier, Le parquet de Paris, l’Inspection Générales des Affaires Sociales (IGAS), Mediator (benflourex), Medicine Théragenomique, Thasso Poste

20justin03 sur Rappel des prothèses mammaires texturées fabriquées par Allergan: “Prothèse mammaire : plaintes contre un fabricant américain ! Une quinzaine de femmes viennent de déposer une série de plaintes…” Fév 7, 14:30
thassodotcom sur Est-ce que des chercheurs ont avalé des études Monsanto sur le Glyphosate?: “Merci pour votre très compétente addition sur le theme.” Fév 4, 05:32
joseph sur Est-ce que des chercheurs ont avalé des études Monsanto sur le Glyphosate?: “les herbicides sont moins toxiques que les insecticides ! mesures de prévention des risques des herbicides néanmoins ! : car,…” Fév 2, 17:36
Menlo-50 sur Le chronotype: la génétique derrière lève-tôt ou couche-tard: “Moi, je me reveille bien à 04.00 heures, chaque jour….. donc un lève-tôt on dit.” Fév 2, 05:31
20urbain05 sur France: L’évaluation du cannabis thérapeutique par le CSST: “Vois la position de l’ANSM vis à vis de l’avis CSST: L’Agence nationale de sécurité du médicament et des produits…” Déc 31, 09:41

Targeted therapy pralsetinib achieves high response rates in advanced cancers with RET gene fusions mai 29, 2020
The targeted therapy pralsetinib appears to have high response rates and durable activity in patients with a broad variety of tumors harboring RET gene fusions, according to results from the international Phase I/II ARROW trial, led by researchers at The University of Texas MD Anderson Cancer Center.
Genetic data may up diagnostic efficiency for rheumatic disease mai 29, 2020
(HealthDay)—Converting genotype information into an interpretable probability value for five different inflammatory arthritis-causing diseases could potentially improve the diagnostic efficiency of rheumatic disease, according to a study published in the May 27 issue of Science Translational Medicine.
New streamlined assay can improve prenatal detection of alpha-thalassemia mai 29, 2020
In a report in The Journal of Molecular Diagnostics, researchers describe a rapid, accurate novel assay for nondeletional alpha-thalassemia genotyping based on one-step nested asymmetric PCR melting curve analysis, which may enhance prenatal diagnosis, newborn screening, and large-scale population screening.
Researchers identify mechanisms that make skin a protective barrier mai 28, 2020
A Mount Sinai research team has identified one of the mechanisms that establish the skin as a protective barrier, a breakthrough that is critical to understanding and treating common skin conditions including eczema and psoriasis, according to a study published Thursday, May 28, in the scientific journal Genes & Development.
Using electrical stimulus to regulate genes mai 28, 2020
This is how it works. A device containing insulin-producing cells and an electronic control unit is implanted in the body of a diabetic. As soon as the patient eats something and their blood sugar rises, they can use an app on their smartphone to trigger an electrical signal, or they can preconfigure the app do […]

The fight goes on: Clinical trial shows promising new treatment for rare blood cancer mai 30, 2020
Although lymphoma is one of the most common types of blood cancer, it has a rare subtype for which no effective treatment regimens are known. For the first time, Nagoya University researchers and colleagues in Japan have conducted clinical trials for a new treatment protocol and report it to be quite promising.
Nanoparticles can make home refrigeration more accessible for low-income households mai 30, 2020
Power consumption of a home refrigerator can be cut by 29% while improving cooling capacity. Researchers replaced environmentally-unfriendly R134a refrigerant with the more energy-efficient R600a. They dosed R600a with multi-walled carbon nanotube (MWCNT) nanoparticles. Drop-in refrigerant replacement in the field by trained technicians is possible, says an engineer from the University of Johannesburg. This test […]
Study reveals factors influencing outcomes in kidney cancer treated with immunotherapy mai 29, 2020
By analyzing tumors from patients treated with immunotherapy for advanced kidney cancer in three clinical trials, Dana-Farber Cancer Institute scientists have identified several features of the tumors that influence their response to immune checkpoint inhibitor drugs.
People more likely to accept nudges if they know how they work and how effective they are mai 29, 2020
The more people know about when and why behavioural interventions are being used and their effectiveness, the more likely they are to accept their use to change their behaviour.
Venous thrombosis among critically ill patients with COVID-19 mai 29, 2020
A systematic assessment of deep vein thrombosis among patients in an intensive care unit in France with severe COVID-19 is reported in this case series.

Social Media, Social Network, Theragenomic Medicine, Social Medicine, Personalized Medicine, Genomic Medicine, Participative Medicine, Targeted Therapy, Individualized Therapy, Personalized Therapy, Individualized Drug Safety, Personalized Drug Safety, Genetic Variants, Allelic Variants, Genotypes, Molecular Phenotypes, Clinical Phenotypes, Companion Test, Heart Disease, Arthritis, Asthma, Diabetes, Hypertension, Malignant Tumors, Breast Cancer, Lung Cancer, Skin Cancer, Erectile Dysfunction, Crowd Sourcing, Patient Sourcing, Participative Sourcing, Collective Experience, Collective Community Wisdom, Apomediary Patient Expert, Patient Cloud,

© 2020 thasso

Responsive WordPress Theme powered by CyberChimps

Top